beta-thujaplicinol has been researched along with efavirenz in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amendola, G; Andreola, ML; Corona, A; Cosconati, S; Costi, R; De Leo, A; De Vita, D; Di Santo, R; Esposito, F; Grandi, N; Ialongo, D; Madia, VN; Messore, A; Métifiot, M; Novellino, E; Saccoliti, F; Scipione, L; Tramontano, E; Tudino, V | 1 |
| Herman, BD; Sluis-Cremer, N | 1 |
2 other study(ies) available for beta-thujaplicinol and efavirenz
| Article | Year |
|---|---|
Quinolinonyl Non-Diketo Acid Derivatives as Inhibitors of HIV-1 Ribonuclease H and Polymerase Functions of Reverse Transcriptase.
Topics: Anti-HIV Agents; HeLa Cells; HIV-1; Humans; Magnesium; Microbial Sensitivity Tests; Molecular Docking Simulation; Mutagenesis, Site-Directed; Mutation; Protein Binding; Quinolones; Reverse Transcriptase Inhibitors; Ribonuclease H, Human Immunodeficiency Virus; Virus Replication | 2021 |
Transient kinetic analyses of the ribonuclease H cleavage activity of HIV-1 reverse transcriptase in complex with efavirenz and/or a β-thujaplicinol analogue.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Binding Sites; Cyclopropanes; HIV Reverse Transcriptase; Kinetics; Reverse Transcriptase Inhibitors; Ribonuclease H; Tropolone | 2013 |